NFKB1 and Hypertension: Additionally, in diabetic rats, sitagliptin prevented the expression of endothelin-1 (ET-1) in the aortic endothelium via inhibiting the NF-κB/inhibitor of the NF-κB system by activation of the AMPK pathway, which produces a vascular protection function against hypertension (114).